Estée Lauder Companies vs Constellation Brands
Global luxury beauty company selling makeup and skincare vs Major North American producer of premium alcoholic beverages. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale channels, putting two consumer companies with pricing power in front of very different post-pandemic demand dynamics. Both rely on brand investment and channel relationships to sustain premium price points. Estee Lauder Companies vs Constellation Brands tracks revenue recovery, channel mix shifts, and which management team is more effectively navigating its sector's unique headwinds.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale ...
Why It’s Moving
Estée Lauder Pledges $15M to Launch Largest Global Breast Cancer Research Initiative for Younger Women
- A new $15 million commitment will fund the Global Research Initiative on Breast Cancer in Younger Women over the next five years.
- The program addresses an alarming global rise in diagnoses among younger demographics through a specialized research coalition.
- This announcement builds upon more than three decades of existing partnership between The Estée Lauder Companies and the Breast Cancer Research Foundation.
STZ slides toward a 52-week low as cautious analysts outweigh Constellation’s reaffirmed outlook.
- STZ touched a new 52-week low at $120.24 on September 18, showing that investors remain focused on soft demand and competitive pressure despite the company’s earnings resilience.
- Jefferies lowered its rating outlook on September 14 by cutting its valuation view while keeping a Hold stance, adding to a series of cautious analyst revisions tied to weaker consumer trends.
- Management reaffirmed its full-year outlook and said supply-chain savings have topped $600 million, but warned that inflation, transportation costs, seasonal effects and heavier marketing spending could pressure second-half margins.
Estée Lauder Pledges $15M to Launch Largest Global Breast Cancer Research Initiative for Younger Women
- A new $15 million commitment will fund the Global Research Initiative on Breast Cancer in Younger Women over the next five years.
- The program addresses an alarming global rise in diagnoses among younger demographics through a specialized research coalition.
- This announcement builds upon more than three decades of existing partnership between The Estée Lauder Companies and the Breast Cancer Research Foundation.
STZ slides toward a 52-week low as cautious analysts outweigh Constellation’s reaffirmed outlook.
- STZ touched a new 52-week low at $120.24 on September 18, showing that investors remain focused on soft demand and competitive pressure despite the company’s earnings resilience.
- Jefferies lowered its rating outlook on September 14 by cutting its valuation view while keeping a Hold stance, adding to a series of cautious analyst revisions tied to weaker consumer trends.
- Management reaffirmed its full-year outlook and said supply-chain savings have topped $600 million, but warned that inflation, transportation costs, seasonal effects and heavier marketing spending could pressure second-half margins.
Investment Analysis
Pros
- Estée Lauder reported Q4 EPS above expectations, showing resilience in a challenging prestige beauty market.
- The company expanded gross margins by 230 basis points, reflecting improved cost management and operational efficiency.
- China sales are stabilising with signs of market share gains, offering potential for future revenue recovery.
Considerations
- Organic sales declined by 8% for the full fiscal year, indicating persistent demand headwinds in key markets.
- Operating margin contracted by 220 basis points, highlighting ongoing profitability pressures despite margin improvements.
- Stock price remains volatile, with recent declines despite earnings beats, reflecting investor concerns over growth prospects.
Pros
- Constellation Brands benefits from exclusive US rights to high-growth Mexican beer brands like Corona and Modelo.
- The company operates with best-of-breed margins and is well-positioned to capitalise on strong secular beverage trends.
- Shares trade at a notable discount to fair value estimates, suggesting potential upside for value-oriented investors.
Considerations
- Recent quarterly EPS declined by 16%, reflecting short-term profitability challenges in the beverage segment.
- The business faces evolving industry dynamics, including shifting consumer preferences and competitive pressures.
- Exposure to regulatory and macroeconomic risks in the alcohol sector could impact future growth and margins.
Estée Lauder Companies (EL) Next Earnings Date
Estée Lauder (NYSE: EL) is currently expected to report its next earnings on November 2, 2026, before the market opens, although the date remains subject to company confirmation. The report should cover fiscal first-quarter 2027, ended September 30, 2026. This timing is consistent with the company’s historical late-October-to-early-November reporting pattern.
Constellation Brands (STZ) Next Earnings Date
Constellation Brands (STZ) is scheduled to report its next earnings on October 6, 2026, after the market close. The report will cover the company’s fiscal second quarter of 2027, ended August 31, 2026. Management is scheduled to host the earnings conference call on October 7, 2026.
Estée Lauder Companies (EL) Next Earnings Date
Estée Lauder (NYSE: EL) is currently expected to report its next earnings on November 2, 2026, before the market opens, although the date remains subject to company confirmation. The report should cover fiscal first-quarter 2027, ended September 30, 2026. This timing is consistent with the company’s historical late-October-to-early-November reporting pattern.
Constellation Brands (STZ) Next Earnings Date
Constellation Brands (STZ) is scheduled to report its next earnings on October 6, 2026, after the market close. The report will cover the company’s fiscal second quarter of 2027, ended August 31, 2026. Management is scheduled to host the earnings conference call on October 7, 2026.
Buy EL or STZ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
